相关实验视频
Updated: Jan 28, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.7K
一个等级复合终点为慢性病在患有焦点细分细胞凝固症的患者慢性病进展
Hiddo J L Heerspink1,2, Dustin J Little3, Samvel B Gasparyan4
1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Clinical journal of the American Society of Nephrology : CJASN
|January 26, 2026
概括
对慢性病 (CKD) 进展的新层次复合终点 (HCE) 在临床试验中更敏感和更有效. 这种HCE提高了评估罕见病治疗方法的统计能力,例如焦点细分质硬化症 (FSGS).
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 临床试验 临床试验
- 生物统计学 生物统计学
背景情况:
- 针对慢性病 (CKD) 进展,开发了一种层次性的复合终点 (HCE),将事件的时间到事件数据与估计的膜过率 (eGFR) 斜率相结合.
- 在罕见病的临床试验中,HCE特别有价值,例如焦点细分结核硬化症 (FSGS),传统的事件驱动试验往往是不可行的.
研究的目的:
- 在DAPA-CKD试验中,将CKD进展HCE应用于FSGS患者.
- 评估使用HCE的FSGS患者治疗CKD进展中的达帕格利弗洛辛的疗效.
- 为了比较HCE的统计能力和效率与标准终点,如初级复合终点和eGFR斜率.
主要方法:
- 利用了DAPA-CKD随机试验中的115名FSGS患者的数据.
- 将达帕格利弗洛辛对初级复合终点,eGFR斜率和新型CKD进展HCE的治疗效应进行比较.
- 采用引导抽样来评估和比较每个结果指标的统计能力.
主要成果:
- 达帕格利弗洛辛在初级复合终点 (HR 0.45) 和eGFR斜率上显示了益处的趋势,但置信区间跨越了单位.
- 慢性瘤进展HCE表明达帕格利弗洛辛具有统计学意义的益处 (胜率:1.52,95%CI:1.01,2.28),置信区间不超过单位.
- 对于CKD进展HCE,与给定样本大小的初级复合终点或eGFR斜率相比,发现其统计能力更高.
结论:
- 慢性瘤进展HCE为FSGS患者评估治疗效果提供了一种敏感且有效的方法.
- HCE 集成已建立的CKD 结果和eGFR 斜率,提高其在临床试验分析中的实用性.
- 建议在未来的临床试验中进行进一步的验证,以支持HCE的更广泛实施.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
697
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
697
01:24Chronic Kidney Disease II: Clinical Manifestations
613
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
613
01:28Chronic Kidney Disease III: Interprofessional Care
387
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
387
01:18Chronic Kidney Disease IV: Nursing Management
363
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
363
01:22Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K